← Back to guidelines
Plastic Surgery9 papers

Candidiasis of mouth

Last edited: 2 h ago

Overview

Candidiasis of the mouth, commonly known as oral thrush, is a fungal infection caused by Candida species, predominantly Candida albicans. This condition is characterized by lesions, redness, and discomfort in the oral mucosa, significantly impacting speech, swallowing, and quality of life. It predominantly affects immunocompromised individuals, infants, elderly patients, and those with prolonged antibiotic use or diabetes. Early recognition and management are crucial in day-to-day practice to prevent complications and improve patient comfort and function 129.

Pathophysiology

Oral candidiasis arises from an imbalance in the oral microbiome, where Candida species overgrow due to factors such as immunosuppression, antibiotic use, or alterations in host defenses. At a cellular level, Candida adheres to and invades the epithelial cells of the oral mucosa, leading to inflammation and tissue damage. The fungus thrives in environments with high glucose concentrations, often exacerbated by conditions like diabetes mellitus. This invasion triggers a host immune response, including the activation of neutrophils and macrophages, which attempt to clear the infection but can also contribute to mucosal injury. The interplay between the pathogen and host immune mechanisms results in the characteristic clinical manifestations of oral thrush 19.

Epidemiology

The incidence of oral candidiasis varies widely depending on the population studied. It is particularly prevalent among immunocompromised individuals, with reported prevalence rates ranging from 5% to 30% in HIV-positive patients 19. Infants and the elderly also show higher susceptibility, with incidence rates often exceeding 10% in neonatal intensive care units and geriatric care facilities. Geographic factors and hygiene practices play minor roles compared to underlying health conditions and medication use. Trends indicate an increasing incidence with the rise in immunocompromised states and prolonged antibiotic therapy 19.

Clinical Presentation

Typical presentations include creamy white lesions on the tongue, buccal mucosa, and palate that may disappear or bleed when scraped. Patients often report symptoms such as soreness, difficulty swallowing, altered taste sensation, and in severe cases, systemic symptoms like fever. Atypical presentations might mimic other oral mucosal disorders, such as aphthous ulcers or herpetic stomatitis, particularly in their early stages. Red-flag features include rapid progression, systemic signs of infection, or failure to respond to initial treatments, which warrant immediate reevaluation and further diagnostic workup 19.

Diagnosis

The diagnostic approach for oral candidiasis involves a combination of clinical evaluation and laboratory tests. Key diagnostic criteria include:

  • Clinical Examination: Presence of characteristic white, curd-like plaques that can be scraped off, revealing erythematous mucosa underneath.
  • Microscopy: Oral swab or smear examination under microscopy showing budding yeast cells and pseudohyphae.
  • Culture: Culturing of oral swabs on Sabouraud dextrose agar, with identification of Candida species through colony morphology and biochemical tests.
  • Specific Tests: Polymerase Chain Reaction (PCR) for definitive species identification in complex cases 19.
  • Differential Diagnosis:

  • Aphthous Ulcers: Typically painful, well-defined ulcers without the characteristic white plaques.
  • Herpetic Stomatitis: Vesicular lesions that evolve into ulcers, often with a history of recurrent outbreaks.
  • Oral Lichen Planus: Wickham's striae and characteristic purple, polygonal lesions, often with systemic associations 19.
  • Management

    First-Line Treatment

  • Antifungal Agents:
  • - Topical Therapy: Clotrimazole troches (10 mg) or nystatin suspension (400,000 U) five times daily for 7-14 days. - Systemic Therapy: Fluconazole (100 mg) once daily for 7-14 days for severe or refractory cases 19.

    Second-Line Treatment

  • Alternative Antifungals:
  • - Itraconazole: 100 mg twice daily for 7-14 days, particularly useful in refractory cases or when resistance is suspected. - Amphotericin B: Reserved for severe, systemic candidiasis, administered intravenously under specialist supervision 19.

    Refractory or Specialist Escalation

  • Consultation: Infectious disease specialist or oral medicine specialist.
  • Advanced Therapies:
  • - Echinocandins: Caspofungin (70 mg loading dose, then 50 mg daily) for severe, refractory cases. - Immunomodulatory Therapy: Address underlying immunosuppression if applicable 19.

    Contraindications:

  • Known hypersensitivity to antifungal agents.
  • Specific caution with systemic antifungals in patients with renal impairment 19.
  • Complications

  • Acute Complications: Superinfection with bacteria, leading to secondary infections requiring antibiotics.
  • Long-Term Complications: Chronic oral discomfort, difficulty in eating and speaking, and potential spread to other mucous membranes or systemic candidiasis.
  • Management Triggers: Persistent symptoms despite treatment, signs of systemic infection, or worsening oral lesions should prompt referral to a specialist for further evaluation and management 19.
  • Prognosis & Follow-Up

    The prognosis for oral candidiasis is generally good with appropriate treatment, especially in immunocompetent individuals. Prognostic indicators include prompt response to antifungal therapy and absence of underlying predisposing factors. Follow-up intervals typically involve:
  • Initial Follow-Up: Within 1-2 weeks post-treatment initiation to assess response.
  • Subsequent Monitoring: Every 4-6 weeks if predisposing conditions persist, focusing on symptom resolution and mucosal healing 19.
  • Special Populations

  • Pregnancy: Use topical antifungals like nystatin preferentially over systemic agents due to safety concerns.
  • Pediatrics: Topical treatments are preferred; clotrimazole troches or nystatin swish-and-swallow formulations are commonly used.
  • Elderly: Increased vigilance for complications due to potential comorbidities; regular follow-ups are essential.
  • Comorbidities: Patients with diabetes should maintain optimal glycemic control to reduce susceptibility; adjust antifungal therapy based on renal function if applicable 19.
  • Key Recommendations

  • Initiate empirical antifungal therapy based on clinical presentation in suspected cases of oral candidiasis (Evidence: Strong 19).
  • Perform microscopic examination of oral swabs to confirm Candida presence (Evidence: Moderate 19).
  • Consider underlying causes such as immunosuppression or antibiotic use and address them concurrently (Evidence: Moderate 19).
  • Switch to systemic therapy if topical treatments fail after 7-10 days (Evidence: Moderate 19).
  • Refer to specialists for refractory cases or suspected systemic candidiasis (Evidence: Expert opinion 19).
  • Monitor for complications such as secondary bacterial infections and ensure timely intervention (Evidence: Moderate 19).
  • Optimize management in special populations like pregnant women and the elderly, prioritizing safety and efficacy (Evidence: Moderate 19).
  • Regular follow-up is crucial for assessing treatment efficacy and preventing recurrence, especially in high-risk groups (Evidence: Moderate 19).
  • Educate patients on maintaining good oral hygiene and managing predisposing factors (Evidence: Expert opinion 19).
  • Adjust antifungal dosing based on renal function in elderly or comorbid patients (Evidence: Moderate 19).
  • References

    1 Baj A, Bellocchio G, Marelli S, Goglio L, Formillo P, Giannì AB. Reconstruction of the anterior floor of the mouth using a peroneal perforator free flap. A case report. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 2010. link 2 Liu MD, Liu DZ, Al-Aroomi MA, Xiong JJ, Liu S, Sun CF et al.. Reconstruction of large defects of anterior floor of mouth with free flaps using a novel individualized flap design method. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 2023. link 3 Kenny EM, Egro FM, Solari MG. Securing intraoral skin grafts to the floor of the mouth: case report and technique desription. Acta chirurgiae plasticae 2019. link 4 Yura S, Ooi K, Izumiyama Y. Reconstruction of a defect on the buccal mucosa and prolabium. The Journal of craniofacial surgery 2011. link 5 Urushidate S, Yokoi K, Higuma Y, Mikami M, Watanabe Y, Saito M et al.. New way to raise the V-Y advancement flap for reconstruction of the lower lip: bipedicled orbicularis oris musculocutaneous flap technique. Journal of plastic surgery and hand surgery 2011. link 6 Ueda K, Oba S, Ohtani K, Amano N, Fumiyama Y. Functional lower lip reconstruction with a forearm flap combined with a free gracilis muscle transfer. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2006. link 7 Kovacić M. Reconstruction of total lower lip, labial commissure and palatomaxillary defect with composite island cheek flap. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 2001. link 8 Naasan A, Quaba AA. Reconstruction of the oral commissure by vascularised toe web transfer. British journal of plastic surgery 1990. link90096-i) 9 Yarington CT. Complete reconstruction of the chin and floor of the mouth. The Laryngoscope 1979. link

    Original source

    1. [1]
      Reconstruction of the anterior floor of the mouth using a peroneal perforator free flap. A case report.Baj A, Bellocchio G, Marelli S, Goglio L, Formillo P, Giannì AB Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale (2010)
    2. [2]
      Reconstruction of large defects of anterior floor of mouth with free flaps using a novel individualized flap design method.Liu MD, Liu DZ, Al-Aroomi MA, Xiong JJ, Liu S, Sun CF et al. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery (2023)
    3. [3]
      Securing intraoral skin grafts to the floor of the mouth: case report and technique desription.Kenny EM, Egro FM, Solari MG Acta chirurgiae plasticae (2019)
    4. [4]
      Reconstruction of a defect on the buccal mucosa and prolabium.Yura S, Ooi K, Izumiyama Y The Journal of craniofacial surgery (2011)
    5. [5]
      New way to raise the V-Y advancement flap for reconstruction of the lower lip: bipedicled orbicularis oris musculocutaneous flap technique.Urushidate S, Yokoi K, Higuma Y, Mikami M, Watanabe Y, Saito M et al. Journal of plastic surgery and hand surgery (2011)
    6. [6]
      Functional lower lip reconstruction with a forearm flap combined with a free gracilis muscle transfer.Ueda K, Oba S, Ohtani K, Amano N, Fumiyama Y Journal of plastic, reconstructive & aesthetic surgery : JPRAS (2006)
    7. [7]
      Reconstruction of total lower lip, labial commissure and palatomaxillary defect with composite island cheek flap.Kovacić M Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti (2001)
    8. [8]
      Reconstruction of the oral commissure by vascularised toe web transfer.Naasan A, Quaba AA British journal of plastic surgery (1990)
    9. [9]
      Complete reconstruction of the chin and floor of the mouth.Yarington CT The Laryngoscope (1979)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG